Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
BMJ Global Health|February 3, 2025
Modelling the health, financial protection and equity impacts of upscaling the ACT NOW early intervention breast cancer pilot program in the Philippines: an extended cost-effectiveness analysisAlexander Chye, Stephen Jan, Nirmala Bhoo Pathy, et al.Kidney International Reports|July 31, 2024
The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A NephropathyDana Kim, Jicheng Lv, Michelle Hladunewich, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 25, 2012
Socioeconomic impact of cancer in member countries of the Association of Southeast Asian Nations (ASEAN): the ACTION study protocolMerel Kimman, Stephen Jan, David Kingston, et al.Kidney International Reports|July 9, 2025
Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFRDana Kim, Brendon L Neuen, Jicheng Lv, et al.Kidney International|January 22, 2026
A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathyMark Canney, Sana Shan, Lee Er, et al.Journal of the American Society of Nephrology : JASN|February 3, 2017
A Trial of Extending Hemodialysis Hours and Quality of LifeMeg J Jardine, Li Zuo, Nicholas A Gray, et al.BMJ Open|October 15, 2025
Integration of precision medicine into routine cancer care-protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trialsShuang Liang, Skye McKay, Frank Lin, et al.The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.JAMA|August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical TrialJicheng Lv, Hong Zhang, Muh Geot Wong, et al.Pageof 3